Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
558 participants
OBSERVATIONAL
2018-11-05
2021-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Study volunteers, seeking to conceive will be provided with Clearblue Ovulation product to help them pinpoint their most fertile time and aid conception. All volunteers will provide daily early morning urine samples throughout the study period and keep a study diary of menses and pregnancy test results for 1 menstrual cycle.
Urine samples will be received in the clinical laboratory and aliquoted into 2.25ml amounts at stored at -80˚C until required.
The study will also gather optional information from volunteers regarding a woman's general health and stress levels when trying to conceive. This will be used to study the relationship between general health, stress and conception.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Early Pregnancy Sample Collection Study
NCT01577147
Consumer in Stream and Container Collected Study
NCT01577901
Clearblue Home Pregnancy Test Consumer Study
NCT01279486
Clearblue Advanced Fertility Monitor Consumer Three Cycle at Home Study
NCT02535260
Late Pregnancy Sample Collection Study
NCT04010682
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Study volunteers, seeking to conceive will be recruited to the study after providing written informed consent. All volunteers will be provided with Clearblue Ovulation product to help them pinpoint their most fertile time and aid conception and be required to collect daily early morning urine samples throughout the study until pregnancy is conformed or their next menstrual period starts. Volunteers will be required to keep a daily diary of menses, sample collection and pregnancy test results. The study will last for 1 menstrual cycle.
Urine samples will be received in the clinical laboratory will be tested for the presence of hormones related to pregnancy and fertility, then aliquoted into 2.25ml amounts at stored in the SPD BioBank at -80˚C until required for product development or evaluation .
The study will also gather optional information from volunteers regarding a woman's general health and stress levels when trying to conceive. This will be used to study the relationship between general health, stress and conception.
Demographic data will be summarised. No statistical analysis will be conducted on the data.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* At least 2 regular consecutive cycles since last pregnancy/miscarriage/or since stopping breastfeeding
* Willing to disclose their pregnancy status and provide urine samples.
* Willing to give informed consent and comply with the investigational procedures.
Exclusion Criteria
* Taking medication, or has known condition which means they should not get pregnant.
* Currently pregnant or breastfeeding
* Abnormal liver or kidney function
* Taking antibiotics containing tetracycline.
* Previously participated in this study
18 Years
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
SPD Development Company Limited
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
sarah Johnson
Role: STUDY_DIRECTOR
SPD Development company Ltd.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
SPD Development Company Ltd
Bedford, Bedfordshire, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PROTOCOL-1015
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.